Major Drug Interaction

Can You Take Paracetamol with Alprazolam?

A plain-English look at the major interaction between Paracetamol (PHARMACY CARE PARACETAMOL) and Alprazolam (Alprax 1) — what it means, why it happens, and what to talk to your doctor or pharmacist about.

Reviewed by , Registered Pharmacist
Last reviewed: How we research and review
Major severity AllMeds interaction database

Taking Paracetamol (PHARMACY CARE PARACETAMOL) with Alprazolam (Alprax 1) is a major drug interaction that should be avoided. Life-threatening respiratory depression, overdose, coma, and death. Additive CNS and respiratory depression. Both drug classes suppress breathing through different mechanisms, creating synergistic respiratory depression that can be fatal.

Not sure about your specific combination? Check it in the Drug Interaction Checker →

Key Takeaways

  • Interaction severity: Major
  • Risk: Life-threatening respiratory depression, overdose, coma, and death.
  • Mechanism: Additive CNS and respiratory depression. Both drug classes suppress breathing through different mechanisms, creating synergistic respiratory depression that can be fatal.
  • Paracetamol: S2 in Australia, low risk
  • Alprazolam: S8 in Australia, moderate risk
  • Claims action: Flag for immediate prescriber review. Document intervention in claim file.

Paracetamol vs Alprazolam at a Glance

Property Paracetamol Alprazolam
Brand names PHARMACY CARE PARACETAMOL, Wagner Health Paracetamol, Paracetamol Sandoz Pharma Alprax 1, Kalma 1, Alprax 0.5
Drug class opioid benzo
Risk level low moderate
TGA Schedule (AU) S2 S8

Why Is This Combination Dangerous?

Additive CNS and respiratory depression. Both drug classes suppress breathing through different mechanisms, creating synergistic respiratory depression that can be fatal.

Clinical risk: Life-threatening respiratory depression, overdose, coma, and death.

Regulatory Guidance by Jurisdiction

Australia TGA / SIRA / WorkSafe

The TGA and Australian Medicines Handbook classify this as a major drug interaction requiring immediate intervention.

All Australian state workers compensation schemes (SIRA NSW, WorkSafe VIC, WorkCover QLD) flag concurrent opioid and benzodiazepine prescribing as high-risk. SIRA best practice guidelines explicitly recommend avoiding this combination except in exceptional circumstances with specialist oversight.

United Kingdom NICE / MHRA / FPM

NICE NG193 (Chronic Pain) recommends against initiating opioids for chronic primary pain. The Faculty of Pain Medicine (FPM) Opioids Aware guidelines strongly advise against concurrent opioid and benzodiazepine prescribing. For personal injury claims in the UK, this combination should be flagged for specialist review. Costs for medication review may be recoverable as a disbursement.

United States FDA / CDC / State WC

The FDA requires a Boxed Warning on all opioid and benzodiazepine products about the risks of concurrent use. The CDC Clinical Practice Guideline (2022) recommends clinicians avoid prescribing opioids and benzodiazepines concurrently whenever possible. Most state workers compensation drug formularies flag or restrict this combination.

What Claims Professionals Should Do

  1. Flag immediately as a high-risk prescribing pattern in the claim file
  2. Request urgent prescriber review with documented clinical justification for the combination
  3. Consider an independent medical examination if the prescriber cannot provide adequate justification
  4. Assess work capacity impact as the combination significantly increases sedation and impairment risk
  5. Document all interventions for audit trail and compliance purposes
  6. Check Reasonable and Necessary status for both medications against the compensable injury

Clinical reference

Informational Regulator-flagged

A clinical summary of Paracetamol and Alprazolam drawn from regulator advisories, national guidelines, and authoritative drug references. Read this if you want the deeper clinical picture before talking to your prescriber or pharmacist.

Severity assessment

Informational. No significant direct drug-drug interaction is reported between alprazolam and paracetamol in official product information or major drug interaction databases.

Mechanism (plain English)

Alprazolam is a benzodiazepine that works by enhancing the effects of a natural chemical in the brain called gamma-aminobutyric acid (GABA). This leads to a calming effect on the central nervous system, reducing anxiety and panic. Paracetamol (also known as acetaminophen) is an analgesic (pain reliever) and antipyretic (fever reducer). Its exact mechanism of action is not fully understood, but it is thought to work primarily in the central nervous system by inhibiting prostaglandin synthesis, which helps to reduce pain and fever. While paracetamol can have some central effects, it is not considered a central nervous system depressant in the same way as alprazolam, and there is no known direct pharmacokinetic (how the body processes the drug) or pharmacodynamic (how the drug affects the body) interaction that would lead to increased side effects or reduced efficacy when these two drugs are taken together.

Evidence level

Regulator-flagged (for individual drug safety profiles); Theoretical (for interaction). The lack of a reported interaction is based on the absence of specific warnings in official product labels for either drug regarding their concomitant use. The FDA label for Alprazolam primarily warns against co-administration with other CNS depressants, particularly opioids, and strong CYP3A inhibitors. The MHRA Summary of Product Characteristics for Paracetamol does not list alprazolam or benzodiazepines as interacting drugs. [DailyMed - ALPRAZOLAM tablet][1]; [MHRA Products | Product results][2]

Top regulator advisories (cite verbatim or close paraphrase)

  • TGA (Australia): No pair-specific public advisory found. The TGA Product Information for alprazolam (e.g., ARTG 341272) generally warns about CNS depressant effects and potential interactions with other CNS depressants, but does not specifically mention paracetamol. For paracetamol, general warnings about liver toxicity with overdose are present.
  • MHRA / NICE (UK): No pair-specific guidance found. The MHRA Summary of Product Characteristics for Paracetamol 500mg Tablets does not list alprazolam or benzodiazepines as interacting drugs. NICE guidelines for pain management do not highlight a specific interaction between these two drugs. [MHRA Products | Product results][2]
  • FDA / CDC (US): No pair-specific safety communication found. The FDA label for Alprazolam (e.g., DailyMed) emphasizes risks from concomitant use with opioids and other CNS depressants, and strong CYP3A inhibitors, but does not list paracetamol as a significant interacting agent. [DailyMed - ALPRAZOLAM tablet][1]
  • EMA (Europe): No specific advisory for this drug pair found. General product information for alprazolam and paracetamol from the EMA would align with the warnings from other regulatory bodies regarding their individual safety profiles.

Clinical risk factors that elevate the danger

While a direct interaction between alprazolam and paracetamol is not expected, certain factors can increase the overall risk when taking either medication:

  • Alprazolam: Concomitant use with other central nervous system (CNS) depressants (e.g., alcohol, opioids, other sedatives) can lead to additive sedative effects, respiratory depression, coma, and death. Patients with a history of substance abuse are at higher risk for alprazolam misuse and dependence. Patients with respiratory compromise or liver impairment may be at increased risk of adverse effects.
  • Paracetamol: Exceeding the recommended dose of paracetamol can lead to severe liver damage, which can be fatal. Risk factors for paracetamol-induced liver damage include chronic alcohol use, malnutrition, and pre-existing liver disease. Taking other medications containing paracetamol unknowingly can also lead to overdose.

What a patient should be told

  • It is generally safe to take alprazolam and paracetamol together at recommended doses, as no significant direct interaction is expected.
  • Always adhere strictly to the prescribed dosage of alprazolam and never exceed the maximum recommended daily dose of paracetamol (typically 4000 mg for adults, but check product-specific instructions). Taking too much paracetamol can cause serious liver damage.
  • Be aware that alprazolam can cause drowsiness, dizziness, and impaired coordination. Avoid driving or operating heavy machinery until you know how you react to the medication. Paracetamol does not typically cause these effects.
  • Do not consume alcohol while taking alprazolam, as this can significantly increase sedation and other side effects. While paracetamol itself does not interact with alcohol in the same way, chronic heavy alcohol use increases the risk of paracetamol-induced liver damage.
  • If you experience unusual drowsiness, difficulty breathing, yellowing of the skin or eyes, dark urine, or severe abdominal pain, seek urgent medical attention. These could be signs of serious adverse effects from either medication.
  • Always inform your doctor or pharmacist about all medications you are taking, including over-the-counter drugs, supplements, and herbal remedies, to ensure safe and effective treatment.

Top 3 sources (with full citation)

  1. DailyMed. (2025, January 15). ALPRAZOLAM tablet. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13930c94-d83a-414f-be35-b1fef35f738d
  2. Medicines and Healthcare products Regulatory Agency. (n.d.). PARACETAMOL 500MG TABLETS Summary of Product Characteristics. Retrieved June 1, 2026, from https://products.mhra.gov.uk/product/?product=PARACETAMOL%20500MG%20TABLETS (Accessed via: https://mhraproducts4853.blob.core.windows.net/docs/0f9377321ad9bcf8e8d79527cb68a1f68d3e7bd2)
  3. Drugs.com. (2025, September 23). Paracetamol: Uses, Dosage, Side Effects, Warnings. https://www.drugs.com/paracetamol.html

Notes for the reviewing pharmacist

This brief highlights the current understanding that there is no direct, clinically significant drug-drug interaction between alprazolam and paracetamol. The primary concerns arise from the individual safety profiles of each drug: the CNS depressant effects and abuse potential of alprazolam, and the hepatotoxicity risk of paracetamol, especially with overdose or in patients with pre-existing liver conditions or chronic alcohol use. Pharmacists should counsel patients on appropriate dosing for both medications, the dangers of combining alprazolam with other CNS depressants (including alcohol), and the importance of not exceeding the maximum daily dose of paracetamol. It is crucial to reinforce that paracetamol is often found in combination products, increasing the risk of accidental overdose. While some research suggests paracetamol may have central effects, these are not typically considered to contribute to a direct interaction with benzodiazepines in a way that necessitates specific warnings beyond general caution for polypharmacy. The evidence level for the interaction itself is theoretical, as no specific regulator warnings or significant case reports directly linking adverse outcomes to this specific combination were found in the primary sources reviewed. The focus should remain on safe use of each drug individually and avoiding known interactions with other substances.

Source metadata JSON

Sources used in this brief (3)

Check this medication against your full medication list

Check all interactions for Paracetamol and Alprazolam across your claimant's full medication list.

Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.

Related Resources

Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.